Lumito AB Share Price

Equities

LUMITO

SE0011282847

Biotechnology & Medical Research

End-of-day quote NORDIC GROWTH MARKET 23:00:00 02/05/2024 BST 5-day change 1st Jan Change
1.238 SEK -0.80% Intraday chart for Lumito AB -8.30% -22.53%

Financials

Sales 2022 - Sales 2023 - Capitalization 330M 30.5M 2.43B
Net income 2022 -27M -2.5M -199M Net income 2023 -25M -2.31M -184M EV / Sales 2022 -
Net cash position 2022 52.71M 4.87M 388M Net cash position 2023 22.45M 2.08M 165M EV / Sales 2023 -
P/E ratio 2022
-9.3 x
P/E ratio 2023
-12.8 x
Employees 15
Yield 2022 *
-
Yield 2023
-
Free-Float 64.61%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.80%
1 week-8.30%
Current month-1.43%
1 month-14.03%
3 months-14.86%
6 months+25.05%
Current year-22.53%
More quotes
1 week
1.24
Extreme 1.238
1.30
1 month
1.24
Extreme 1.238
1.50
Current year
1.10
Extreme 1.1
1.80
1 year
0.81
Extreme 0.806
2.41
3 years
0.48
Extreme 0.48
2.53
5 years
0.48
Extreme 0.48
9.00
10 years
0.48
Extreme 0.48
9.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 07/03/21
Chairman 67 15/08/17
Director of Finance/CFO 66 31/03/18
Members of the board TitleAgeSince
Director/Board Member 60 03/06/19
Founder 64 31/12/17
Director/Board Member 69 03/06/19
More insiders
Date Price Change Volume
03/05/24 1.238 -0.80% 156,506
02/05/24 1.248 -0.64% 239,787
30/04/24 1.256 -3.38% 219,296
29/04/24 1.3 -3.70% 269,369
26/04/24 1.35 +5.47% 518,400

End-of-day quote NORDIC GROWTH MARKET, May 02, 2024

More quotes
Lumito AB (publ) is a Sweden-based company engaged in the healthcare sector. The Company focuses on the research of technology within the diagnostics for tissue samples. The Company develops an instrument and reagents for digital pathology, including digitized tissue diagnostics where the analysis is remote and supported with computer-based tools.
Calendar
More about the company
  1. Stock Market
  2. Equities
  3. LUMITO Stock